Application of Ultrasound Integrated Precision Diagnosis Technology in Prevention of Kidney Disease and Its Progress
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 208
- 试验地点
- 2
- 主要终点
- Number of patients with creatinine increasing by more than 50%
研究概览
简要总结
In this study, a prospective, randomized and controlled clinical study would be carried out to establish Ultrasound Integrated Precision Diagnosis Technology with elastography as the core technology to evaluate renal injury and repair comprehensively and accurately, and to improve the clinical diagnosis chance of renal injury (or renal fibrosis).
Combined with the dynamic changes of biomarkers (inflammatory factors, cytokines secreted by immune cells, etc.) after kidney injury, the research on the prognosis of kidney disease with ultrasound elastography technology as the core would be explored, which aims to provide a scientific basis for the application of Ultrasound Integrated Precision Diagnosis Technology.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Number of patients with creatinine increasing by more than 50%
时间窗: 1st month-12 month
Number of patients with creatinine increasing by more than 50% of baseline.
Rate of death
时间窗: 1st month-12 month
for all patients
Number of patients with initiation of continuous renal replacement therapy
时间窗: 1st month-12 month
for non-transplantation patient
次要结局
- Number of patients with cardiovascular events(1st month-12 month)
- Number of patients with new serious infections requiring hospitalization(1st month-12 month)
- Number of patients with cerebrovascular events(1st month-12 month)